Wednesday 28 July is World Hepatitis Day. Hepatitis is an inflammation of the liver, most commonly caused by viral infection. One of the world’s leading causes of death, viral hepatitis kills as many people worldwide as HIV/AIDS, malaria or tuberculosis. In 2019, WHO estimated... Read more
Decentralized clinical trials (DCTs) have been central to the continuation of vital clinical studies throughout the COVID-19 pandemic. Previously the uptake of decentralized models has been slow, but the pandemic changed this. There is now consensus among industry leaders that... Read more

As the clinical trials sector begins to recover from the impacts of the COVID-19 pandemic, Cromos Pharma’s US BD Director, Nicole Brenna, discussed how her interactions with clients have shown ... Read more

This July, Cromos Pharma is highlighting Sarcoma Awareness Month. Sarcomas are rare malignant cancer tumors that start in the bones and soft tissues. The most common type of sarcoma is soft tissue sarcoma. Four out of five sarcomas occur in soft issues. Over half of the... Read more

Cromos Pharma is delighted to announce a new initiative offering Free Feasibility Reports to sponsors considering expanding their clinical trials into Central and Eastern Europe. 

Read more
Cromos Pharma has published (29 June 2021) an updated country profile about conducting clinical trials in Poland. As an international clinical research organization, Cromos has been managing clinical trials in this country since 2015. Read about the significant advantages on o... Read more
The number of cancer survivors is rising worldwide, due to advances in early detection and treatment as well as the aging of the world’s population. This June, Cromos Pharma celebrates Read more
A good clinical study protocol is the foundation for a successful clinical trial. A well-designed and written protocol is vital for protecting patients, allowing for collection of high-quality data, and preventing delays in development timelines. In this article Cromos Ph... Read more